Arrhythmia Research Technology, Inc. v. Corazonix Corporation

958 F.2d 1053, 1992 WL 45435
CourtCourt of Appeals for the Federal Circuit
DecidedMay 5, 1992
Docket91-1091
StatusPublished
Cited by37 cases

This text of 958 F.2d 1053 (Arrhythmia Research Technology, Inc. v. Corazonix Corporation) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Arrhythmia Research Technology, Inc. v. Corazonix Corporation, 958 F.2d 1053, 1992 WL 45435 (Fed. Cir. 1992).

Opinions

PAULINE NEWMAN, Circuit Judge.

Arrhythmia Research Technology, Inc. appeals the grant of summary judgment by the United States District Court for the Northern District of Texas1 declaring United States Patent No. 4,422,459 to Michael B. Simson (the '459 or Simson patent) invalid for failure to claim statutory subject matter under 35 U.S.C. § 101. The court did not decide the question of infringement.

We conclude that the claimed subject matter is statutory in terms of section 101. The judgment of invalidity on this ground is reversed.

The Simson Invention

The invention claimed in the '459 patent is directed to the analysis of electrocardio-graphic signals in order to determine certain characteristics of the heart function. In the hours immediately after a heart attack (myocardial infarction) the victim is particularly vulnerable to an acute type of heart arrhythmia known as ventricular tachycardia. Ventricular tachycardia leads quickly to ventricular fibrillation, in which the heart ceases effectively to pump blood through the body. Arrhythmia Research states that 15-25% of heart attack victims are at high risk for ventricular tachycardia. It can be treated or prevented with certain drugs, but these drugs have undesirable and sometimes dangerous side effects. Dr. Simson, a cardiologist, sought a solution to the problem of determining which heart attack victims are at high risk for ventricular tachycardia, so that these persons can be carefully monitored and appropriately treated.

Heart activity is monitored by means of an electrocardiograph device, whereby electrodes attached to the patient’s body detect the heart’s electrical signals in accordance with the various phases of heart activity. The signals can be displayed in wave form on a monitor and/or recorded on a chart. It was known that in patients subject to ventricular tachycardia certain anomalous waves having very low amplitude and high frequency, known as “late potentials,” appear toward the end of the QRS2 segment of the electrocardiographic signal, that is, late in the ventricular contraction cycle. Dr. Simson’s method of detecting and measuring these late potentials in the QRS complex, and associated apparatus, are the subject of the ’459 patent.

[1055]*1055The ’459 patent specification describes these procedures. Certain of the heart attack patient’s electrocardiographic signals, those obtained from electrodes designated as X, Y, and Z leads, are converted from analog to digital values, and a composite digital representation of the QRS segment is obtained by selecting and averaging a large number of the patient’s QRS waveforms. The anterior portion of the composite QRS waveform is first isolated, and then processed by a digital high pass filter in reverse time order; that is, backwards. This step of reverse time order filtering is described as the critical feature of the Sim-son invention, in that it enables detection of the late potentials by eliminating certain perturbations that obscure these signals. The root mean square of the reverse time filtered output is then calculated, as described in the specification, to determine the average magnitude of the anterior portion of the QRS complex. Comparison of the output, which is measured in micro-volts, with a predetermined level of high frequency energy, indicates whether the patient is subject to ventricular tachycardia. That is, if the root mean square magnitude is less than the predetermined level, then low amplitude, high frequency late potentials have been shown to be present, indicating a higher risk of ventricular tachycardia. If the root mean square value is greater than the predetermined level, high risk for ventricular tachycardia is not indicated.

Certain steps of the invention are described as conducted with the aid of a digital computer, and the patent specification sets forth the mathematical formulae that are used to configure (program) the computer. The specification states that dedicated, specific purpose equipment or hard wired logic circuitry can also be used.

The district court held that the method and apparatus claims of the Simson patent are directed to a mathematical algorithm, and thus do not define statutory subject matter. Claim 1 is the broadest method claim:

1. A method for analyzing electrocardiograph signals to determine the presence or absence of a predetermined level of high frequency energy in the late QRS signal, comprising the steps of:
converting a series of QRS signals to time segments, each segment having a digital value equivalent to the analog value of said signals at said time;
applying a portion of said time segments in reverse time order to high pass filter means;
determining an arithmetic value of the amplitude of the output of said filter; and
comparing said value with said predetermined level.

Claim 7 is a representative apparatus claim:

7. Apparatus for analyzing electrocardiograph signals to determine the level of high frequency energy in the late QRS signal comprising:
means for converting X, Y, and Z lead electrocardiographic input signals to digital valued time segments;
means for examining said X, Y, and Z digital valued time segments and selecting therefrom the QRS waveform portions thereof;
means for signal averaging a multiplicity of said selected QRS waveforms for each of said X, Y, and Z inputs and providing composite, digital X, Y, and Z QRS waveforms;
high pass filter means;
means for applying to said filter means, in reverse time order, the anteri- or portion of each said digital X, Y, and Z waveform; and
means for comparing the output of said filter means with a predetermined level to obtain an indication of the presence of a high frequency, low level, energy component in the filter output of said anterior portions.

The Patent and Trademark Office had granted the patent without questioning that its claims were directed to statutory subject matter under § 101.

35 U.S.C. § 101

Whether a claim is directed to statutory subject matter is a question of law. Al[1056]*1056though determination of this question may require findings of underlying facts specific to the particular subject matter and its mode of claiming, in this case there were no disputed facts material to the issue. Thus we give plenary review to the question, with appropriate recognition of the burdens on the challenger of a duly issued United States patent. See 35 U.S.C. § 282 (duly issued patent is presumed valid); Interconnect Planning Corp. v. Feil, 774 F.2d 1132, 1139, 227 USPQ 543, 548, (Fed.Cir.1985) (statutory presumption of validity is based in part on recognition of the expertise of patent examiners).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

DDR Holdings, LLC v. Hotels.Com, L.P.
954 F. Supp. 2d 509 (E.D. Texas, 2013)
CLS Bank International v. Alice Corp. Pty. Ltd.
717 F.3d 1269 (Federal Circuit, 2013)
CLS Bank International v. Alice Corp. Pty. Ltd.
768 F. Supp. 2d 221 (District of Columbia, 2011)
Voter Verified, Inc. v. Election Systems & Software, Inc.
745 F. Supp. 2d 1237 (M.D. Florida, 2010)
Voter Verified, Inc. v. Premier Election Solutions, Inc.
739 F. Supp. 2d 1340 (M.D. Florida, 2010)
CyberSource Corp. v. Retail Decisions, Inc.
620 F. Supp. 2d 1068 (N.D. California, 2009)
In Re Comiskey [Revised]
Federal Circuit, 2009
In Re Comiskey
554 F.3d 967 (Federal Circuit, 2009)
In Re Bilski
545 F.3d 943 (Federal Circuit, 2008)
In Re Nuijten
515 F.3d 1361 (Federal Circuit, 2007)
Ariad Pharmaceuticals, Inc. v. Eli Lilly & Co.
529 F. Supp. 2d 106 (D. Massachusetts, 2007)
In re Bonczyk
10 F. App'x 908 (Federal Circuit, 2001)
John H. Bruning v. Ryusho Hirose
161 F.3d 681 (Federal Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
958 F.2d 1053, 1992 WL 45435, Counsel Stack Legal Research, https://law.counselstack.com/opinion/arrhythmia-research-technology-inc-v-corazonix-corporation-cafc-1992.